These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1707136)

  • 1. Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes.
    Gerosa F; Tommasi M; Scardoni M; Accolla RS; Pozzan T; Libonati M; Tridente G; Carra G
    Mol Immunol; 1991; 28(1-2):159-68. PubMed ID: 1707136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69.
    Sánchez-Mateos P; Sánchez-Madrid F
    Eur J Immunol; 1991 Oct; 21(10):2317-25. PubMed ID: 1717281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
    Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
    Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor.
    Nagasawa R; Gross J; Kanagawa O; Townsend K; Lanier LL; Chiller J; Allison JP
    J Immunol; 1987 Feb; 138(3):815-24. PubMed ID: 2433330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).
    Ciccone E; Ferrini S; Bottino C; Viale O; Prigione I; Pantaleo G; Tambussi G; Moretta A; Moretta L
    J Exp Med; 1988 Jul; 168(1):1-11. PubMed ID: 2456364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of transgenic mice for the production of a human monoclonal antibody specific for human CD69 antigen.
    Molina A; Valladares M; Magadán S; Sancho D; Viedma F; Sanjuan I; Gambón F; Sánchez-Madrid F; González-Fernández A
    J Immunol Methods; 2003 Nov; 282(1-2):147-58. PubMed ID: 14604548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
    Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
    J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.
    Schwartz-Albiez R; Dörken B; Monner DA; Moldenhauer G
    Int Immunol; 1991 Jul; 3(7):623-33. PubMed ID: 1716973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
    Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L
    J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells.
    Bieber T; Rieger A; Stingl G; Sander E; Wanek P; Strobel I
    J Invest Dermatol; 1992 May; 98(5):771-6. PubMed ID: 1569326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1.
    Nakamura S; Sung SS; Bjorndahl JM; Fu SM
    J Exp Med; 1989 Mar; 169(3):677-89. PubMed ID: 2466940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a murine T cell surface disulfide-linked dimer of 45-kDa glycopeptides (YE1/48 antigen). Comparison with T cell receptor, purification, and partial amino acid sequences.
    Chan PY; Takei F
    J Immunol; 1988 Jan; 140(1):161-9. PubMed ID: 3121737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
    Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
    Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb.
    Hérold C; Bismuth G; Bensussan A; Boumsell L
    Int Immunol; 1995 Jan; 7(1):1-8. PubMed ID: 7718506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.